Impact of VEGF polymorphisms on the severity of peripheral artery disease in diabetic patients

References

• Berse B, Brown LF, van de Water L, Dvorak HF, Senger DR. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 3:211–220.
   PubMed Web of Science ®Google Scholar
• Biselli PM, Guerzoni AR, de Godoy MF, Pavarino-Bertelli EC, Goloni-Bertollo EM. 2008. Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population. Heart Vessels. 23 6: 371–375.
   PubMed Web of Science ®Google Scholar
• Bleda S, De Haro J, Acin F, Varela C, Esparza L. Enhanced vascular endothelial growth factor gene expression in ischaemic skin of critical limb ischaemia patients. Int J Vasc Med. 2012a Article ID 691528, 4 pages.
   Google Scholar
• Bleda S, De Haro J, Varela C, Esparza L, Ferruelo A, Acin F. Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in type II diabetic patients. Diab Vasc Dis Res. 2012b; 9 1: 68–74.
   Google Scholar
• Bloor K. 1961. Natural history of artherosclerosis of the lower extremities. Ann R Coll Surg Engl. 28:36–52.
   Google Scholar
• Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L. 2007. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol Dial Transplant. 22:827–832.
   PubMed Web of Science ®Google Scholar
• De Haro J, Acin F, Lopez-Quintana A, Florez A, Martinez-Aguilar E, Varela C. 2009. Meta-analysis of randomized, controlled clinical trials in angiogenesis: Gene and cell therapy in peripheral arterial disease. Heart Vessels. 24 5: 321–328.
   Google Scholar
• Guerzoni AR, Biselli PM, Godoy MF, Souza DR, Haddad R, Eberlin MN, Pavarino-Bertelli EC, Goloni-Bertollo EM. 2009. Homocysteine MTHFR and VEGF gene polymorphisms: Impact on coronary artery disease. Arg Bras Cardiol. 92 4: 263–268.
   Google Scholar
• Howell WM, Ali S, Rose-Zerilli MJ, Ye S. 2005. VEGF polymorphisms and severity of atherosclerosis. J Med Genet. 42 6: 485–490.
   PubMed Web of Science ®Google Scholar
• Lin Th, Su HM, Wang CL, Voon WC, Shin SJ, Lai WT, Sheu SH. 2010. Vascular endothelial growth factor polymorphisms and extent of coronary atherosclerosis in Chinese population with advanced coronary artery disease. Am J Hypertens. 23 9: 960–966.
   Google Scholar
• Mundet X, Cano F, Mata-Cases M, Roura P, Franch J, Birutes M, Gimbert R, Llusa J, Cos X. 2012. Trends in chronic complications of type 2 diabetic patients from Spanish primary health care centers (GEDAPS Study): Ten year-implementation of St Vicent recommendations. Prim Care Diabetes. 6 1: 11–18.
   Google Scholar
• Muntner P, Wildman RP, Reynolds K, Desalvo KB, Chen J, Fonseca V. 2005. Relationship between HbA1c level and peripheral arterial disease. Diabetes Care. 28 8: 1981–1987.
   PubMed Web of Science ®Google Scholar
• Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. 2007. TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 45:S5–S67.
   PubMed Web of Science ®Google Scholar
• Ohashi J, Yamamoto S, Tsuchiya N, Hatta Y, Komata T, Matsushita M, Tokunaga K. 2001. Comparison of statistical power between 2 × 2 allele frequency and allele positivity tables in case-control studies of complex disease genes. Ann Hum Genet. 65:197–206.
   Google Scholar
• Stehr A, Töpel I, Müller S, Unverdorben K, Geissler EK, Kasprzak PM, Schlitt HJ, Steinbauer M. 2010. VEGF: A surrogate marker for peripheral vascular disease. Eur J Vasc Endovasc Surg. 39:330–332.
   Google Scholar
• Tsurumi Y, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner JM. 1997. Reciprocal relationship between VEGF and NO in the regulation of endothelial integrity. Nature Med. 3:879–886.
   PubMed Web of Science ®Google Scholar
• Vural P, Küskü-Kiraz Z, Doğru-Abbasoğlu S, Cil E, Karadağ B, Uysal M. 2010. Vascular endothelial growth factor +405 G/C, − 460 T/C and − 2578 A/C polymorphisms are not associated with insulin resistance in polycystic ovary syndrome. Int J Immunogenet. 37 4: 239–243.
   Google Scholar
• Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC. 2000. Identification of polymorphisms in the promoter and 5′ untranslated regions of the human vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine. 12:1232–1235.
   PubMed Web of Science ®Google Scholar